早期胃癌淋巴结转移评估方法的研究现状

doi:10.11904/j.issn.1002-3070.2020.03.019

摘要/Abstract

摘要： 早期胃癌的定义为癌灶仅局限于黏膜层或黏膜下层,无论病灶大小及有无淋巴结转移。研究证实淋巴结转移是早期胃癌的独立预后因素,并且对评估早期胃癌患者的预后以及指导治疗具有重要临床意义。评估早期胃癌淋巴结转移的方法有很多,临床上常常应用CT及超声内镜等影像学检查评估早期胃癌淋巴结转移,此外病理活检、分子标志物及前哨淋巴结示踪活检等方法也在早期胃癌淋巴结转移的评估中占有重要位置,本文就早期胃癌淋巴结转移相关评估方法现状予以综述。

关键词: 早期胃癌, 淋巴结转移, 影像学评估, 分子标志物

Abstract: Early gastric cancer is defined as cancerous foci that are confined to the mucosa or submucosal layer,regardless of the size of the lesion and the presence or absence of lymph node metastasis.Studies have confirmed that lymph node metastasis is an independent prognostic factor for early gastric cancer,and has important clinical significance for assessing the prognosis of early gastric cancer patients and guiding treatment.There are many methods for assessing lymph node metastasis in the early gastric cancer.CT and ultrasound endoscopy are often used to evaluate lymph node metastasis in the early gastric cancer.In addition,pathological biopsy,molecular markers,and sentinel lymph node tracking biopsy are also used in the early gastric cancer.It plays an important role in the evaluation of this disease.This article reviews the current status of assessment methods for lymph node metastasis in the early gastric cancer.

Key words: Early gastric cancer, Lymph node metastasis, Imaging evaluation, Molecular marker

中图分类号:

R735.2

石琳娜, 隋红. 早期胃癌淋巴结转移评估方法的研究现状[J]. 实用肿瘤学杂志, 2020, 34(3): 286-290.

SHI Linna,SUI Hong. Research status for evaluation methods of lymph node metastasis in the early gastric cancer[J]. Journal of Practical Oncology, 2020, 34(3): 286-290.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/10.11904/j.issn.1002-3070.2020.03.019

http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/Y2020/V34/I3/286

参考文献

1 Chen WQ,Zheng RS,Baade PD,et al.Cancer statistics in China2015[J].CA Cancer Clin,2016,66(2):115-132.
2 Xuan L,Liu SY,Jin Y,et al.The characteristics,prognosis,and risk factors of lymph node metastasis in early gastric cancer[J].Gastroent Res Pract,2018,2018(5):1-7.
3 Wang YW,Zhu ML,Wang RF,et al.Predictable factors for lymph node metastasis in early gastric cancer analysis of clinicopathologic factors and biologic markers[J].Tumour Biol,2016,37(7):8567-8578.
4 Saito H,Fukuoto Y,Osaki T,et al.Prognostic significance of the ratio between metastatic and dissected lymph nodes in patients with advanced gastric cancer[J].Surg Oncol,2010,97(97):132-135.
5 Quan RL,Zhu HX,Yu W,et al.Correlation between clinicopathological features and lymph node metastasis in early gastric cancer[J].Anhui Medicine,2019,40(5):500-503.
6 Choi KK,Bae JM,Kim SM,et al.The risk of lymph node metastases in 3951 surgically resected mucosal gastric cancers:implications for endoscopic resection[J].Gastrointest Endosc,2016,83(5);896-901.
7 Gulluoglu M,Yegen G,Ozluk Y,et al.Tumor budding is independently predictive for lymph node involvement in early gastric cancer[J].Int J Surg Pathol,2015,23(5):349-358.
8 陈光勇,黄受方,内镜下胃黏膜切除标本病理学规范检查的建议[J].中华病理学杂志,2014,43(5):344-347.
9 Kunisak IC,Shimada H,Nomura M,et al.Distribution of lymph node metastasis in gastric carcionma[J].Hepatogastroenterolog,2006,53(69):468-472.
10 Mamou J,Saegusa-Beecroft E,Coron A,et al.Three-dimensional quantitative ultrasound to guide pathologists towards metastatic foci in lymph nodes[J].Conf Proc IEEE Eng Med Biol Soc,2012,2012:1114-1117.
11 Pellicano R,Bruno M,Fagoonee S,et al.Endoscopic ultrasound in the preoperative staging of gastric cancer:key messages for surgeons[J].Minerva Chirurgica,2015,70(6):417-427.
12 Ahmad R,Setia N,Schmidt BH,et al.Predictors of lymph node metastasis in western early gastric cancer[J].Gastrointest Surg,2016,20(3):531-538.
13 Shay G,Tauro M,Loiodice F,et al.Selective inhibition of matrix metalloproteinase-2 in the multiple myeloma-bone microenvironment[J].Oncotarget,2017,8(26):41827-41840.
14 Yao ZH,Yuan T,Wang HY,et al.MMP-2 together with MMP-9 overexpression correlated with lymph node metastasis and poor prognosis in early gastric carcinoma[J].Tumor Biology,2017,39(6):1-8.
15 Tan BX,Khoo KH,Lim TM,et al.High MDM4 levels suppress p53 activity and enhance its half-life in acute myeloid leukaemia[J].Oncotarget,2014,5(4):933-943.
16 Bao J,Nanding A,Song H,et al.The overexpression of MDM4:an effective and novel predictor of gastric adenocarcinoma lymph node metastasis[J].Oncotarget,2016,7(41):67212-67222.
17 Gao Y,Xu D,Yu G,et al.Overexpression of metabolic markers HK1 and PKM2 contributes to lymphatic metastasis and adverse prognosis in Chinese gastric cancer[J].Int J Clin Exp Pathol,2015,8(8):9264-9271.
18 Bartel DP.MicroRNAs:target recognition and regulatory functions [J].Cell,2009,136(2):215-233.
19 谢静,王天娇,张旭凤,等.MicroRNA和NF－κB与胃癌侵袭转移关系的研究进展[J].实用肿瘤学杂志,2016,30(4):380-384.
20 Liu L,Ye JX,Qin YZ,et al.Evaluation of miR-29c,miR-124,miR-135a and miR-148a in predicting lymph node metastasis and tumor stage of gastric cancer[J].Int Clin Exp Med,2015,8(12):22227-22236.
21 Yang H,Fu H,Wang B,et al.Exosomal miR-423-5p targets SUFU to promote cancer growth and metastasis and serves as a novel marker for gastric cancer[J].Molecular Carcinogenesis,2018,57(9):1223-1236.
22 Tian SB,JC Y,Kang WM,et al.Combined detection of CEA,CA199,CA242 and CA50 in the diagnosis and prognosis of resectable gastric cancer [J].Asian Pac J Cancer Prev,2014,15(15):6295-6300.
23 Feng F,Tian Y,Xu G,et al.Diagnostic and prognostic value of CEA,CA199,AFP and CA125 for early gastric cancer [J].BMC Cancer,2017,(737):1-6.
24 Lee YR,Joo HK,Lee EO,et al.ATP binding cassette transporter A1 is involved in extracellular secretion of acetylated APE1/Ref-1 [J].Int J Mol Sci,2019,20(13):1-14.
25 Wei X,Li Q,Li Y,et al.Prediction of survival prognosis of non-small cell lung cancer by APE1 through regulation of epithelial-mesenchymal transition [J].Oncotarget,2016,7(19):28523-28539.
26 Wei X,Li YB,Li Y,et al.Prediction of lymph node metastases in gastric cancer by serum APE1 expression [J].Cancer,2017,8:1492-1497.
27 Mueller CL,Lisbona R,Sorial R,et al.Sentinel lymph node sampling for early gastric cancer-preliminary results of a north american prospective study[J].Gastrointest Surg,2019,23:1113-1112.
28 Takeuchi H.Sentinel lymph node biopsy in gastric cancer[J].Cancer J,2015,21(1):21-24.

[1]	郭永东, 靳晶, 李利敏, 贺宇彤. 分化拮抗非蛋白质编码RNA(DANCR)在常见恶性肿瘤中的研究进展[J]. 实用肿瘤学杂志, 2020, 34(1): 69-73.
[2]	张宁, 兰雪玲. 铁蛋白在头颈癌颈部淋巴结转移的预测作用[J]. 实用肿瘤学杂志, 2019, 33(5): 442-446.
[3]	孟海,杜观祥,朱利玲,汤琪云. WEE1在胃癌组织中的表达及对患者预后的影响[J]. 实用肿瘤学杂志, 2019, 33(3): 239-243.
[4]	徐俊, 张恩勇, 罗天航, 薛绪潮, 崔航天, 方国恩. 早期胃混合型印戒细胞癌的临床病理因素分析[J]. 实用肿瘤学杂志, 2016, 30(5): 414-419.
[5]	冯卓颖, 鹿瑶, 苏雁欣, 都杨. Logistic回归模型在超声评价甲状腺结节良恶性及淋巴转移的应用研究[J]. 实用肿瘤学杂志, 2015, 29(5): 385-389.
[6]	徐京京, 杨明, 赵娟, 周艳华, 张艳桥. 胰腺癌切除术后预后相关因素的临床分析[J]. 实用肿瘤学杂志, 2012, 26(6): 543-547.
[7]	修骋, 裴荣, 孙冀. 中期因子在喉癌中的表达及其临床意义[J]. 实用肿瘤学杂志, 2011, 25(2): 120-125.
[8]	郭学光, 陈正堂. CCR7活化与人结肠癌SW620细胞的体外增殖、趋化与侵袭的关系[J]. 实用肿瘤学杂志, 2010, 24(4): 365-367.
[9]	刘改新, 邓元娥, 詹兴娜. 影响手术治疗宫颈癌患者预后的相关因素[J]. 实用肿瘤学杂志, 2008, 22(6): 528-529.
[10]	黄秋实;史成章;王红建;秦先锋. Maspin蛋白及uPA在结肠癌组织中的表达及其临床意义[J]. 实用肿瘤学杂志, 2008, 22(03): 220-223.
[11]	王敏;陈桂林;黄燕玲;陈琴. 子宫内膜癌手术范围探讨[J]. 实用肿瘤学杂志, 2008, 22(03): 248-249,.
[12]	何晓燕;何雪云;郑俊. 甲状腺乳头状癌中PCNA的表达及意义[J]. 实用肿瘤学杂志, 2008, 22(03): 263-264.
[13]	蒿业红;谷安鑫;鄂明艳. 食管癌膈下转移淋巴结放疗前后血流变化与疗效的关系[J]. 实用肿瘤学杂志, 2007, 21(06): 553-554.
[14]	田振囡;胡杨. 青年乳腺癌病理特点-附60例病例分析[J]. 实用肿瘤学杂志, 2007, 21(04): 338-339,.
[15]	卓明英;杨军;张丽娥;赵阳红;黄小靖;吴茜;杨峰;林兴;林翠珍. 甲状腺乳头状腺癌CD44V6、p53蛋白的表达及意义[J]. 实用肿瘤学杂志, 2007, 21(03): 253-254,.